Baccara-Dinet M - Search Results

1

[Patients' paths to a designated reference center for severe obesity: the example of the Montpellier Regional Hospital Center].

Baccara-Dinet M, Bonnin M, Nocca D, de Seguin des Hons C, Lefebvre P, Daynes B, Renard E, Robles G, Fabre JM, Bringer J. Baccara-Dinet M, et al. Presse Med. 2010 Mar;39(3):323-31. doi: 10.1016/j.lpm.2009.04.011. Epub 2009 Sep 5. Presse Med. 2010. PMID: 19734005 French.

2

Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.

Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA. Fontbonne A, et al. Diabetes Metab. 2009 Nov;35(5):385-91. doi: 10.1016/j.diabet.2009.03.005. Epub 2009 Aug 7. Diabetes Metab. 2009. PMID: 19665415 Clinical Trial.

3

Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.

Bruckert E, Baccara-Dinet M, Eschwege E. Bruckert E, et al. Diabet Med. 2007 Apr;24(4):388-91. doi: 10.1111/j.1464-5491.2007.02111.x. Epub 2007 Feb 28. Diabet Med. 2007. PMID: 17335463

4

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.

5

Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study.

Nam CW, Kim DS, Li J, Baccara-Dinet MT, Li I, Kim JH, Kim CJ. Nam CW, et al. Korean J Intern Med. 2019 Nov;34(6):1252-1262. doi: 10.3904/kjim.2018.133. Epub 2018 Sep 1. Korean J Intern Med. 2019. PMID: 30257549 Free PMC article. Clinical Trial.

6

Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies).

Teramoto T, Kobayashi M, Uno K, Takagi Y, Matsuoka O, Sugimoto M, Inoue S, Minami F, Baccara-Dinet MT. Teramoto T, et al. Am J Cardiol. 2016 Jul 1;118(1):56-63. doi: 10.1016/j.amjcard.2016.04.011. Epub 2016 Apr 21. Am J Cardiol. 2016. PMID: 27184170 Free article. Clinical Trial.

7

Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study.

Janik MJ, Urbach DV, van Nieuwenhuizen E, Zhao J, Yellin O, Baccara-Dinet MT, Pordy R, Manvelian G. Janik MJ, et al. Among authors: baccara dinet mt. Atherosclerosis. 2021 Aug;331:20-27. doi: 10.1016/j.atherosclerosis.2021.06.913. Epub 2021 Jun 27. Atherosclerosis. 2021. PMID: 34303265 Free article. Clinical Trial.

8

Are physicians able to identify high-risk abdominally obese individuals? An analysis from the pan-European Survey of HDL-cholesterol.

Baccara-Dinet M, Bruckert E. Baccara-Dinet M, et al. Curr Med Res Opin. 2007 Aug;23(8):2005-8. doi: 10.1185/030079907X225439. Curr Med Res Opin. 2007. PMID: 17637201

9

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia.

Kastelein JJ, Ginsberg HN, Langslet G, Hovingh GK, Ceska R, Dufour R, Blom D, Civeira F, Krempf M, Lorenzato C, Zhao J, Pordy R, Baccara-Dinet MT, Gipe DA, Geiger MJ, Farnier M. Kastelein JJ, et al. Eur Heart J. 2015 Nov 14;36(43):2996-3003. doi: 10.1093/eurheartj/ehv370. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330422 Free PMC article. Clinical Trial.

10

High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients.

Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. Bruckert E, et al. Curr Med Res Opin. 2005 Dec;21(12):1927-34. doi: 10.1185/030079905X74871. Curr Med Res Opin. 2005. PMID: 16368042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters